Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 14;194(1):54–66. doi: 10.1111/cei.13185

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

(a) The percentage of CD4⁺CD25⁺forkhead box protein 3 (FoxP3)⁺regulatory T cells (T_regs) among lymphocytes following culture with interferon dendritic dells/peptide and zoledronate plus α‐galactosylceramide (IFN DCs/P+Z+G) from patients (patients 1, 2 and 4) was lower than that following culture with IFN DCs/P. (b) Statistical analysis showed that the percentage of CD4⁺CD25⁺FoxP3⁺ T_regs among lymphocytes following culture with IFN DCs/P+Z+G from patients was significantly lower than the percentage of CD4⁺CD25⁺FoxP3⁺T_regs among lymphocytes following culture with IFN DCs/P (4·22±2·00% versus 5·05±1·93%, P < 0·01).